Gsk (GSK) Income After Tax (2009 - 2026)
Gsk (GSK) posted Income After Tax of $2.91 billion for the quarter ended Sep 30, 2026, down 22.1% from $3.74 billion a year earlier.
Powered by 
Analysis
Gsk (GSK) Income After Tax (2009 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Income After Tax at Gsk was $16.92 billion, up 65.8% year-over-year; for the year ended Dec 31, 2025, it came in at $8.29 billion, up 119.8% from the prior year.
- Annual Income After Tax shows a five-year compound annual growth rate of 6.1% (years ended Dec 2020 to Dec 2025).
- In prior years, Gsk's Income After Tax was $3.77 billion in the year ended Dec 31, 2024 (-42.9%), $6.6 billion in the year ended Dec 31, 2023 (+8.4%), $6.09 billion in the year ended Dec 31, 2022 (+25.9%) and $4.84 billion in the year ended Dec 31, 2021 (-21.7%).
- Quarterly Income After Tax has run from a low of $81.86 million in the quarter ended Sep 30, 2024 to a high of $11.32 billion in the quarter ended Dec 31, 2025 over five years.
- On a year-over-year basis, Income After Tax increased in four of the last seven quarters, with growth averaging 100.3%.
- The strongest year-over-year quarter for Income After Tax in the past five years was the quarter ended Dec 31, 2022, with growth of 991.4%; the weakest was the quarter ended Sep 30, 2024, with a decline of 96.8%.
- According to Business Quant data, Income After Tax for the three prior quarters was $207.96 million (quarter ended Jun 30, 2026), $2.48 billion (quarter ended Mar 31, 2026) and $11.32 billion (quarter ended Dec 31, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income After Tax (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 4.80 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 3.25 Bn |
| 10 | Gsk | 102.08 Bn | 84.92 Bn | 8.73 Bn | 2.91 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 2.91 Bn |
| Jun 30, 2026 | 207.96 Mn |
| Mar 31, 2026 | 2.48 Bn |
| Dec 31, 2025 | 11.32 Bn |
| Sep 30, 2025 | 3.74 Bn |
| Jun 30, 2025 | 2.84 Bn |
| Mar 31, 2025 | 2.23 Bn |
| Dec 31, 2024 | 1.40 Bn |
| Sep 30, 2024 | 81.86 Mn |
| Jun 30, 2024 | 2.13 Bn |
| Mar 31, 2024 | 1.37 Bn |
| Dec 31, 2023 | 1.41 Bn |
| Sep 30, 2023 | 2.59 Bn |
| Jun 30, 2023 | 2.79 Bn |
| Mar 31, 2023 | 1.98 Bn |
| Dec 31, 2022 | 2.74 Bn |
| Sep 30, 2022 | 1.47 Bn |
| Jun 30, 2022 | 1.32 Bn |
| Mar 31, 2022 | 2.38 Bn |
| Dec 31, 2021 | 250.73 Mn |
API Access
Gsk Income After Tax API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=profit-after-tax&ticker=GSK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "profit-after-tax", "ticker": "GSK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=profit-after-tax&ticker=GSK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();